nodes	percent_of_prediction	percent_of_DWPC	metapath
Amiodarone—CYP3A4—bone cancer	0.582	1	CbGaD
Amiodarone—Anaphylactoid reaction—Epirubicin—bone cancer	0.00047	0.00169	CcSEcCtD
Amiodarone—Eczema—Doxorubicin—bone cancer	0.000468	0.00169	CcSEcCtD
Amiodarone—Hepatic failure—Doxorubicin—bone cancer	0.000468	0.00169	CcSEcCtD
Amiodarone—Cardiac failure—Epirubicin—bone cancer	0.000466	0.00168	CcSEcCtD
Amiodarone—Cardiac failure congestive—Doxorubicin—bone cancer	0.000464	0.00167	CcSEcCtD
Amiodarone—Ataxia—Methotrexate—bone cancer	0.000457	0.00165	CcSEcCtD
Amiodarone—Renal failure acute—Doxorubicin—bone cancer	0.000456	0.00164	CcSEcCtD
Amiodarone—Anxiety—Cisplatin—bone cancer	0.000453	0.00163	CcSEcCtD
Amiodarone—Hot flush—Doxorubicin—bone cancer	0.00045	0.00162	CcSEcCtD
Amiodarone—Liver function test abnormal—Methotrexate—bone cancer	0.000449	0.00162	CcSEcCtD
Amiodarone—Discomfort—Cisplatin—bone cancer	0.000449	0.00162	CcSEcCtD
Amiodarone—Dermatitis exfoliative—Doxorubicin—bone cancer	0.000446	0.00161	CcSEcCtD
Amiodarone—Menopausal symptoms—Doxorubicin—bone cancer	0.000446	0.00161	CcSEcCtD
Amiodarone—Renal impairment—Doxorubicin—bone cancer	0.000442	0.00159	CcSEcCtD
Amiodarone—Toxic epidermal necrolysis—Methotrexate—bone cancer	0.000438	0.00158	CcSEcCtD
Amiodarone—Anaphylactic shock—Cisplatin—bone cancer	0.000435	0.00157	CcSEcCtD
Amiodarone—Oedema—Cisplatin—bone cancer	0.000435	0.00157	CcSEcCtD
Amiodarone—Anaphylactoid reaction—Doxorubicin—bone cancer	0.000435	0.00157	CcSEcCtD
Amiodarone—Cardiac arrest—Epirubicin—bone cancer	0.000432	0.00156	CcSEcCtD
Amiodarone—Infection—Cisplatin—bone cancer	0.000432	0.00156	CcSEcCtD
Amiodarone—Cardiac failure—Doxorubicin—bone cancer	0.000431	0.00155	CcSEcCtD
Amiodarone—Ataxia—Epirubicin—bone cancer	0.000428	0.00154	CcSEcCtD
Amiodarone—Thrombocytopenia—Cisplatin—bone cancer	0.000426	0.00154	CcSEcCtD
Amiodarone—Tachycardia—Cisplatin—bone cancer	0.000425	0.00153	CcSEcCtD
Amiodarone—Skin disorder—Cisplatin—bone cancer	0.000423	0.00152	CcSEcCtD
Amiodarone—Hyperhidrosis—Cisplatin—bone cancer	0.000421	0.00152	CcSEcCtD
Amiodarone—Liver function test abnormal—Epirubicin—bone cancer	0.00042	0.00151	CcSEcCtD
Amiodarone—Eosinophilia—Methotrexate—bone cancer	0.000416	0.0015	CcSEcCtD
Amiodarone—Anorexia—Cisplatin—bone cancer	0.000415	0.0015	CcSEcCtD
Amiodarone—Pancreatitis—Methotrexate—bone cancer	0.000412	0.00148	CcSEcCtD
Amiodarone—Aspartate aminotransferase increased—Epirubicin—bone cancer	0.00041	0.00148	CcSEcCtD
Amiodarone—Toxic epidermal necrolysis—Epirubicin—bone cancer	0.00041	0.00148	CcSEcCtD
Amiodarone—Hypotension—Cisplatin—bone cancer	0.000407	0.00147	CcSEcCtD
Amiodarone—Muscular weakness—Epirubicin—bone cancer	0.000401	0.00145	CcSEcCtD
Amiodarone—Alanine aminotransferase increased—Epirubicin—bone cancer	0.000401	0.00145	CcSEcCtD
Amiodarone—Cardiac arrest—Doxorubicin—bone cancer	0.0004	0.00144	CcSEcCtD
Amiodarone—Pancytopenia—Methotrexate—bone cancer	0.000399	0.00144	CcSEcCtD
Amiodarone—Ataxia—Doxorubicin—bone cancer	0.000396	0.00143	CcSEcCtD
Amiodarone—Neutropenia—Methotrexate—bone cancer	0.000393	0.00142	CcSEcCtD
Amiodarone—Paraesthesia—Cisplatin—bone cancer	0.000391	0.00141	CcSEcCtD
Amiodarone—Eosinophilia—Epirubicin—bone cancer	0.000389	0.0014	CcSEcCtD
Amiodarone—Liver function test abnormal—Doxorubicin—bone cancer	0.000389	0.0014	CcSEcCtD
Amiodarone—Dyspnoea—Cisplatin—bone cancer	0.000388	0.0014	CcSEcCtD
Amiodarone—Erectile dysfunction—Methotrexate—bone cancer	0.000387	0.00139	CcSEcCtD
Amiodarone—Pancreatitis—Epirubicin—bone cancer	0.000385	0.00139	CcSEcCtD
Amiodarone—Photosensitivity reaction—Methotrexate—bone cancer	0.000383	0.00138	CcSEcCtD
Amiodarone—Angina pectoris—Epirubicin—bone cancer	0.000383	0.00138	CcSEcCtD
Amiodarone—Toxic epidermal necrolysis—Doxorubicin—bone cancer	0.000379	0.00137	CcSEcCtD
Amiodarone—Aspartate aminotransferase increased—Doxorubicin—bone cancer	0.000379	0.00137	CcSEcCtD
Amiodarone—Decreased appetite—Cisplatin—bone cancer	0.000378	0.00136	CcSEcCtD
Amiodarone—Pneumonia—Methotrexate—bone cancer	0.000377	0.00136	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Cisplatin—bone cancer	0.000376	0.00136	CcSEcCtD
Amiodarone—Pancytopenia—Epirubicin—bone cancer	0.000373	0.00135	CcSEcCtD
Amiodarone—Pain—Cisplatin—bone cancer	0.000372	0.00134	CcSEcCtD
Amiodarone—Stevens-Johnson syndrome—Methotrexate—bone cancer	0.000371	0.00134	CcSEcCtD
Amiodarone—Muscular weakness—Doxorubicin—bone cancer	0.000371	0.00134	CcSEcCtD
Amiodarone—Alanine aminotransferase increased—Doxorubicin—bone cancer	0.000371	0.00134	CcSEcCtD
Amiodarone—Renal failure—Methotrexate—bone cancer	0.000368	0.00133	CcSEcCtD
Amiodarone—Neutropenia—Epirubicin—bone cancer	0.000368	0.00133	CcSEcCtD
Amiodarone—Eosinophilia—Doxorubicin—bone cancer	0.00036	0.0013	CcSEcCtD
Amiodarone—Sweating—Methotrexate—bone cancer	0.000359	0.00129	CcSEcCtD
Amiodarone—Photosensitivity reaction—Epirubicin—bone cancer	0.000359	0.00129	CcSEcCtD
Amiodarone—Feeling abnormal—Cisplatin—bone cancer	0.000359	0.00129	CcSEcCtD
Amiodarone—Weight increased—Epirubicin—bone cancer	0.000358	0.00129	CcSEcCtD
Amiodarone—Pancreatitis—Doxorubicin—bone cancer	0.000357	0.00129	CcSEcCtD
Amiodarone—Weight decreased—Epirubicin—bone cancer	0.000356	0.00128	CcSEcCtD
Amiodarone—Angina pectoris—Doxorubicin—bone cancer	0.000354	0.00128	CcSEcCtD
Amiodarone—Pneumonia—Epirubicin—bone cancer	0.000353	0.00127	CcSEcCtD
Amiodarone—Agranulocytosis—Methotrexate—bone cancer	0.00035	0.00126	CcSEcCtD
Amiodarone—Stevens-Johnson syndrome—Epirubicin—bone cancer	0.000347	0.00125	CcSEcCtD
Amiodarone—Pancytopenia—Doxorubicin—bone cancer	0.000345	0.00125	CcSEcCtD
Amiodarone—Renal failure—Epirubicin—bone cancer	0.000345	0.00124	CcSEcCtD
Amiodarone—Body temperature increased—Cisplatin—bone cancer	0.000344	0.00124	CcSEcCtD
Amiodarone—Neuropathy peripheral—Epirubicin—bone cancer	0.000344	0.00124	CcSEcCtD
Amiodarone—Jaundice—Epirubicin—bone cancer	0.000342	0.00123	CcSEcCtD
Amiodarone—Neutropenia—Doxorubicin—bone cancer	0.00034	0.00123	CcSEcCtD
Amiodarone—Hepatitis—Methotrexate—bone cancer	0.000336	0.00121	CcSEcCtD
Amiodarone—Sweating—Epirubicin—bone cancer	0.000336	0.00121	CcSEcCtD
Amiodarone—Photosensitivity reaction—Doxorubicin—bone cancer	0.000332	0.0012	CcSEcCtD
Amiodarone—Weight increased—Doxorubicin—bone cancer	0.000331	0.00119	CcSEcCtD
Amiodarone—Weight decreased—Doxorubicin—bone cancer	0.000329	0.00119	CcSEcCtD
Amiodarone—Agranulocytosis—Epirubicin—bone cancer	0.000327	0.00118	CcSEcCtD
Amiodarone—Pneumonia—Doxorubicin—bone cancer	0.000326	0.00118	CcSEcCtD
Amiodarone—Visual impairment—Methotrexate—bone cancer	0.000324	0.00117	CcSEcCtD
Amiodarone—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.000322	0.00116	CcSEcCtD
Amiodarone—Hypersensitivity—Cisplatin—bone cancer	0.000321	0.00116	CcSEcCtD
Amiodarone—Bradycardia—Epirubicin—bone cancer	0.00032	0.00115	CcSEcCtD
Amiodarone—Renal failure—Doxorubicin—bone cancer	0.000319	0.00115	CcSEcCtD
Amiodarone—Erythema multiforme—Methotrexate—bone cancer	0.000318	0.00115	CcSEcCtD
Amiodarone—Neuropathy peripheral—Doxorubicin—bone cancer	0.000318	0.00115	CcSEcCtD
Amiodarone—Jaundice—Doxorubicin—bone cancer	0.000316	0.00114	CcSEcCtD
Amiodarone—Hepatitis—Epirubicin—bone cancer	0.000315	0.00113	CcSEcCtD
Amiodarone—Tinnitus—Methotrexate—bone cancer	0.000313	0.00113	CcSEcCtD
Amiodarone—Asthenia—Cisplatin—bone cancer	0.000312	0.00113	CcSEcCtD
Amiodarone—Sweating—Doxorubicin—bone cancer	0.000311	0.00112	CcSEcCtD
Amiodarone—Visual impairment—Epirubicin—bone cancer	0.000303	0.00109	CcSEcCtD
Amiodarone—Agranulocytosis—Doxorubicin—bone cancer	0.000303	0.00109	CcSEcCtD
Amiodarone—CACNA2D2—Transmission across Chemical Synapses—BRAF—bone cancer	0.000299	0.00213	CbGpPWpGaD
Amiodarone—Diarrhoea—Cisplatin—bone cancer	0.000298	0.00107	CcSEcCtD
Amiodarone—Erythema multiforme—Epirubicin—bone cancer	0.000298	0.00107	CcSEcCtD
Amiodarone—Alopecia—Methotrexate—bone cancer	0.000297	0.00107	CcSEcCtD
Amiodarone—THRA—Gene Expression—NR1I2—bone cancer	0.000297	0.00211	CbGpPWpGaD
Amiodarone—THRB—Gene Expression—NR1I2—bone cancer	0.000297	0.00211	CbGpPWpGaD
Amiodarone—Bradycardia—Doxorubicin—bone cancer	0.000296	0.00107	CcSEcCtD
Amiodarone—CYP1A2—Estrogen Receptor Pathway—JUN—bone cancer	0.000294	0.0021	CbGpPWpGaD
Amiodarone—Tinnitus—Epirubicin—bone cancer	0.000293	0.00106	CcSEcCtD
Amiodarone—Erythema—Methotrexate—bone cancer	0.000293	0.00106	CcSEcCtD
Amiodarone—Flushing—Epirubicin—bone cancer	0.000292	0.00105	CcSEcCtD
Amiodarone—CYP3A5—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000292	0.00208	CbGpPWpGaD
Amiodarone—Hepatitis—Doxorubicin—bone cancer	0.000291	0.00105	CcSEcCtD
Amiodarone—Dysgeusia—Methotrexate—bone cancer	0.000287	0.00103	CcSEcCtD
Amiodarone—Back pain—Methotrexate—bone cancer	0.000283	0.00102	CcSEcCtD
Amiodarone—Arrhythmia—Epirubicin—bone cancer	0.000281	0.00101	CcSEcCtD
Amiodarone—Visual impairment—Doxorubicin—bone cancer	0.000281	0.00101	CcSEcCtD
Amiodarone—ADRB1—Calcium Regulation in the Cardiac Cell—GNA11—bone cancer	0.000278	0.00198	CbGpPWpGaD
Amiodarone—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000278	0.00198	CbGpPWpGaD
Amiodarone—Alopecia—Epirubicin—bone cancer	0.000278	0.001	CcSEcCtD
Amiodarone—Vomiting—Cisplatin—bone cancer	0.000277	0.000998	CcSEcCtD
Amiodarone—Vision blurred—Methotrexate—bone cancer	0.000276	0.000995	CcSEcCtD
Amiodarone—CYP1A1—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000276	0.00196	CbGpPWpGaD
Amiodarone—Erythema multiforme—Doxorubicin—bone cancer	0.000275	0.000993	CcSEcCtD
Amiodarone—CYP2C19—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000275	0.00196	CbGpPWpGaD
Amiodarone—Rash—Cisplatin—bone cancer	0.000274	0.00099	CcSEcCtD
Amiodarone—Dermatitis—Cisplatin—bone cancer	0.000274	0.000989	CcSEcCtD
Amiodarone—Erythema—Epirubicin—bone cancer	0.000274	0.000988	CcSEcCtD
Amiodarone—Ill-defined disorder—Methotrexate—bone cancer	0.000272	0.000979	CcSEcCtD
Amiodarone—Tinnitus—Doxorubicin—bone cancer	0.000271	0.000979	CcSEcCtD
Amiodarone—Flushing—Doxorubicin—bone cancer	0.00027	0.000974	CcSEcCtD
Amiodarone—Dysgeusia—Epirubicin—bone cancer	0.000268	0.000967	CcSEcCtD
Amiodarone—CYP1A2—Tryptophan metabolism—CYP3A4—bone cancer	0.000268	0.00191	CbGpPWpGaD
Amiodarone—Back pain—Epirubicin—bone cancer	0.000265	0.000955	CcSEcCtD
Amiodarone—Malaise—Methotrexate—bone cancer	0.000264	0.000952	CcSEcCtD
Amiodarone—Vertigo—Methotrexate—bone cancer	0.000263	0.000948	CcSEcCtD
Amiodarone—Arrhythmia—Doxorubicin—bone cancer	0.00026	0.000938	CcSEcCtD
Amiodarone—Nausea—Cisplatin—bone cancer	0.000259	0.000932	CcSEcCtD
Amiodarone—Vision blurred—Epirubicin—bone cancer	0.000258	0.000931	CcSEcCtD
Amiodarone—Alopecia—Doxorubicin—bone cancer	0.000257	0.000928	CcSEcCtD
Amiodarone—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000256	0.00182	CbGpPWpGaD
Amiodarone—Cough—Methotrexate—bone cancer	0.000255	0.000921	CcSEcCtD
Amiodarone—Ill-defined disorder—Epirubicin—bone cancer	0.000254	0.000916	CcSEcCtD
Amiodarone—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000254	0.00181	CbGpPWpGaD
Amiodarone—Erythema—Doxorubicin—bone cancer	0.000253	0.000914	CcSEcCtD
Amiodarone—CYP2C8—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000253	0.0018	CbGpPWpGaD
Amiodarone—CYP2D6—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000253	0.0018	CbGpPWpGaD
Amiodarone—Agitation—Epirubicin—bone cancer	0.000252	0.000908	CcSEcCtD
Amiodarone—CYP2C9—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.00025	0.00178	CbGpPWpGaD
Amiodarone—CACNA2D2—Transmission across Chemical Synapses—MDM2—bone cancer	0.00025	0.00178	CbGpPWpGaD
Amiodarone—Dysgeusia—Doxorubicin—bone cancer	0.000248	0.000895	CcSEcCtD
Amiodarone—Malaise—Epirubicin—bone cancer	0.000247	0.000891	CcSEcCtD
Amiodarone—Discomfort—Methotrexate—bone cancer	0.000246	0.000888	CcSEcCtD
Amiodarone—Vertigo—Epirubicin—bone cancer	0.000246	0.000887	CcSEcCtD
Amiodarone—Back pain—Doxorubicin—bone cancer	0.000245	0.000884	CcSEcCtD
Amiodarone—Confusional state—Methotrexate—bone cancer	0.000241	0.000868	CcSEcCtD
Amiodarone—Cough—Epirubicin—bone cancer	0.000239	0.000862	CcSEcCtD
Amiodarone—Anaphylactic shock—Methotrexate—bone cancer	0.000239	0.000861	CcSEcCtD
Amiodarone—Vision blurred—Doxorubicin—bone cancer	0.000239	0.000861	CcSEcCtD
Amiodarone—Infection—Methotrexate—bone cancer	0.000237	0.000856	CcSEcCtD
Amiodarone—Ill-defined disorder—Doxorubicin—bone cancer	0.000235	0.000848	CcSEcCtD
Amiodarone—Thrombocytopenia—Methotrexate—bone cancer	0.000234	0.000843	CcSEcCtD
Amiodarone—Agitation—Doxorubicin—bone cancer	0.000233	0.00084	CcSEcCtD
Amiodarone—Anxiety—Epirubicin—bone cancer	0.000232	0.000838	CcSEcCtD
Amiodarone—Skin disorder—Methotrexate—bone cancer	0.000232	0.000837	CcSEcCtD
Amiodarone—Hyperhidrosis—Methotrexate—bone cancer	0.000231	0.000833	CcSEcCtD
Amiodarone—Discomfort—Epirubicin—bone cancer	0.00023	0.000831	CcSEcCtD
Amiodarone—CACNA2D2—Neuronal System—BRAF—bone cancer	0.000229	0.00163	CbGpPWpGaD
Amiodarone—Malaise—Doxorubicin—bone cancer	0.000229	0.000824	CcSEcCtD
Amiodarone—Dry mouth—Epirubicin—bone cancer	0.000228	0.000822	CcSEcCtD
Amiodarone—Vertigo—Doxorubicin—bone cancer	0.000228	0.000821	CcSEcCtD
Amiodarone—Anorexia—Methotrexate—bone cancer	0.000228	0.000821	CcSEcCtD
Amiodarone—CYP1A1—Aryl Hydrocarbon Receptor—RB1—bone cancer	0.000227	0.00161	CbGpPWpGaD
Amiodarone—CYP2C19—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000226	0.00161	CbGpPWpGaD
Amiodarone—Confusional state—Epirubicin—bone cancer	0.000225	0.000813	CcSEcCtD
Amiodarone—Oedema—Epirubicin—bone cancer	0.000224	0.000806	CcSEcCtD
Amiodarone—Anaphylactic shock—Epirubicin—bone cancer	0.000224	0.000806	CcSEcCtD
Amiodarone—Hypotension—Methotrexate—bone cancer	0.000223	0.000805	CcSEcCtD
Amiodarone—Infection—Epirubicin—bone cancer	0.000222	0.000801	CcSEcCtD
Amiodarone—Cough—Doxorubicin—bone cancer	0.000221	0.000797	CcSEcCtD
Amiodarone—Shock—Epirubicin—bone cancer	0.00022	0.000793	CcSEcCtD
Amiodarone—THRA—Gene Expression—EIF2S1—bone cancer	0.000219	0.00156	CbGpPWpGaD
Amiodarone—THRB—Gene Expression—EIF2S1—bone cancer	0.000219	0.00156	CbGpPWpGaD
Amiodarone—Thrombocytopenia—Epirubicin—bone cancer	0.000219	0.000789	CcSEcCtD
Amiodarone—Tachycardia—Epirubicin—bone cancer	0.000218	0.000787	CcSEcCtD
Amiodarone—Skin disorder—Epirubicin—bone cancer	0.000217	0.000783	CcSEcCtD
Amiodarone—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000217	0.00154	CbGpPWpGaD
Amiodarone—CACNA1H—Axon guidance—MET—bone cancer	0.000216	0.00154	CbGpPWpGaD
Amiodarone—Hyperhidrosis—Epirubicin—bone cancer	0.000216	0.000779	CcSEcCtD
Amiodarone—Insomnia—Methotrexate—bone cancer	0.000216	0.000779	CcSEcCtD
Amiodarone—Anxiety—Doxorubicin—bone cancer	0.000215	0.000775	CcSEcCtD
Amiodarone—Paraesthesia—Methotrexate—bone cancer	0.000214	0.000773	CcSEcCtD
Amiodarone—CYP3A7—Biological oxidations—CYP3A4—bone cancer	0.000214	0.00153	CbGpPWpGaD
Amiodarone—CYP1A2—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000214	0.00152	CbGpPWpGaD
Amiodarone—Discomfort—Doxorubicin—bone cancer	0.000213	0.000769	CcSEcCtD
Amiodarone—Anorexia—Epirubicin—bone cancer	0.000213	0.000768	CcSEcCtD
Amiodarone—Dyspnoea—Methotrexate—bone cancer	0.000213	0.000768	CcSEcCtD
Amiodarone—CYP3A7—Metapathway biotransformation—CYP3A4—bone cancer	0.000212	0.00151	CbGpPWpGaD
Amiodarone—Dry mouth—Doxorubicin—bone cancer	0.000211	0.000761	CcSEcCtD
Amiodarone—Dyspepsia—Methotrexate—bone cancer	0.00021	0.000758	CcSEcCtD
Amiodarone—ADRB1—GPCR ligand binding—GRM4—bone cancer	0.00021	0.00149	CbGpPWpGaD
Amiodarone—Hypotension—Epirubicin—bone cancer	0.000209	0.000753	CcSEcCtD
Amiodarone—Confusional state—Doxorubicin—bone cancer	0.000209	0.000752	CcSEcCtD
Amiodarone—Decreased appetite—Methotrexate—bone cancer	0.000208	0.000749	CcSEcCtD
Amiodarone—CYP2D6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000208	0.00148	CbGpPWpGaD
Amiodarone—Oedema—Doxorubicin—bone cancer	0.000207	0.000746	CcSEcCtD
Amiodarone—Anaphylactic shock—Doxorubicin—bone cancer	0.000207	0.000746	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Methotrexate—bone cancer	0.000206	0.000744	CcSEcCtD
Amiodarone—Fatigue—Methotrexate—bone cancer	0.000206	0.000743	CcSEcCtD
Amiodarone—CYP2C9—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000206	0.00146	CbGpPWpGaD
Amiodarone—Infection—Doxorubicin—bone cancer	0.000205	0.000741	CcSEcCtD
Amiodarone—Pain—Methotrexate—bone cancer	0.000204	0.000737	CcSEcCtD
Amiodarone—Shock—Doxorubicin—bone cancer	0.000203	0.000734	CcSEcCtD
Amiodarone—Thrombocytopenia—Doxorubicin—bone cancer	0.000203	0.00073	CcSEcCtD
Amiodarone—Insomnia—Epirubicin—bone cancer	0.000202	0.000729	CcSEcCtD
Amiodarone—Tachycardia—Doxorubicin—bone cancer	0.000202	0.000728	CcSEcCtD
Amiodarone—Skin disorder—Doxorubicin—bone cancer	0.000201	0.000724	CcSEcCtD
Amiodarone—Paraesthesia—Epirubicin—bone cancer	0.000201	0.000724	CcSEcCtD
Amiodarone—Hyperhidrosis—Doxorubicin—bone cancer	0.0002	0.000721	CcSEcCtD
Amiodarone—Dyspnoea—Epirubicin—bone cancer	0.000199	0.000719	CcSEcCtD
Amiodarone—Anorexia—Doxorubicin—bone cancer	0.000197	0.000711	CcSEcCtD
Amiodarone—Feeling abnormal—Methotrexate—bone cancer	0.000197	0.00071	CcSEcCtD
Amiodarone—Dyspepsia—Epirubicin—bone cancer	0.000197	0.00071	CcSEcCtD
Amiodarone—CYP2A6—Biological oxidations—CYP3A4—bone cancer	0.000197	0.0014	CbGpPWpGaD
Amiodarone—Gastrointestinal pain—Methotrexate—bone cancer	0.000195	0.000704	CcSEcCtD
Amiodarone—Decreased appetite—Epirubicin—bone cancer	0.000194	0.000701	CcSEcCtD
Amiodarone—CYP2A6—Fluoropyrimidine Activity—TP53—bone cancer	0.000194	0.00138	CbGpPWpGaD
Amiodarone—CYP1A1—Tryptophan metabolism—MDM2—bone cancer	0.000193	0.00138	CbGpPWpGaD
Amiodarone—Hypotension—Doxorubicin—bone cancer	0.000193	0.000697	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Epirubicin—bone cancer	0.000193	0.000696	CcSEcCtD
Amiodarone—Fatigue—Epirubicin—bone cancer	0.000193	0.000695	CcSEcCtD
Amiodarone—CACNA2D2—Neuronal System—MDM2—bone cancer	0.000192	0.00136	CbGpPWpGaD
Amiodarone—CYP2A6—NRF2 pathway—TGFBR2—bone cancer	0.000192	0.00136	CbGpPWpGaD
Amiodarone—CYP2A6—NRF2 pathway—GSTP1—bone cancer	0.000192	0.00136	CbGpPWpGaD
Amiodarone—Pain—Epirubicin—bone cancer	0.000191	0.000689	CcSEcCtD
Amiodarone—Constipation—Epirubicin—bone cancer	0.000191	0.000689	CcSEcCtD
Amiodarone—THRA—Gene Expression—EZH2—bone cancer	0.00019	0.00136	CbGpPWpGaD
Amiodarone—THRB—Gene Expression—EZH2—bone cancer	0.00019	0.00136	CbGpPWpGaD
Amiodarone—Urticaria—Methotrexate—bone cancer	0.00019	0.000684	CcSEcCtD
Amiodarone—Body temperature increased—Methotrexate—bone cancer	0.000189	0.000681	CcSEcCtD
Amiodarone—Abdominal pain—Methotrexate—bone cancer	0.000189	0.000681	CcSEcCtD
Amiodarone—EBP—Metabolism—ENO2—bone cancer	0.000187	0.00134	CbGpPWpGaD
Amiodarone—Insomnia—Doxorubicin—bone cancer	0.000187	0.000675	CcSEcCtD
Amiodarone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—bone cancer	0.000186	0.00133	CbGpPWpGaD
Amiodarone—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—bone cancer	0.000186	0.00133	CbGpPWpGaD
Amiodarone—Paraesthesia—Doxorubicin—bone cancer	0.000186	0.00067	CcSEcCtD
Amiodarone—Dyspnoea—Doxorubicin—bone cancer	0.000184	0.000665	CcSEcCtD
Amiodarone—Feeling abnormal—Epirubicin—bone cancer	0.000184	0.000664	CcSEcCtD
Amiodarone—CYP3A7—Biological oxidations—GSTP1—bone cancer	0.000183	0.00131	CbGpPWpGaD
Amiodarone—Gastrointestinal pain—Epirubicin—bone cancer	0.000183	0.000659	CcSEcCtD
Amiodarone—Dyspepsia—Doxorubicin—bone cancer	0.000182	0.000656	CcSEcCtD
Amiodarone—ADRB1—GPCR ligand binding—GRM1—bone cancer	0.000182	0.00129	CbGpPWpGaD
Amiodarone—CYP3A7—Metapathway biotransformation—GSTP1—bone cancer	0.000181	0.00129	CbGpPWpGaD
Amiodarone—CACNA1H—Axon guidance—MMP2—bone cancer	0.00018	0.00128	CbGpPWpGaD
Amiodarone—Decreased appetite—Doxorubicin—bone cancer	0.00018	0.000648	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000179	0.000644	CcSEcCtD
Amiodarone—Fatigue—Doxorubicin—bone cancer	0.000178	0.000643	CcSEcCtD
Amiodarone—Urticaria—Epirubicin—bone cancer	0.000178	0.00064	CcSEcCtD
Amiodarone—Constipation—Doxorubicin—bone cancer	0.000177	0.000638	CcSEcCtD
Amiodarone—Pain—Doxorubicin—bone cancer	0.000177	0.000638	CcSEcCtD
Amiodarone—Abdominal pain—Epirubicin—bone cancer	0.000177	0.000637	CcSEcCtD
Amiodarone—Body temperature increased—Epirubicin—bone cancer	0.000177	0.000637	CcSEcCtD
Amiodarone—Hypersensitivity—Methotrexate—bone cancer	0.000176	0.000635	CcSEcCtD
Amiodarone—CYP1A2—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000176	0.00125	CbGpPWpGaD
Amiodarone—CYP1A1—Arachidonic acid metabolism—PTGS2—bone cancer	0.000174	0.00124	CbGpPWpGaD
Amiodarone—EBP—Metabolism—DHFR—bone cancer	0.000174	0.00124	CbGpPWpGaD
Amiodarone—Asthenia—Methotrexate—bone cancer	0.000171	0.000618	CcSEcCtD
Amiodarone—Feeling abnormal—Doxorubicin—bone cancer	0.00017	0.000615	CcSEcCtD
Amiodarone—Gastrointestinal pain—Doxorubicin—bone cancer	0.000169	0.00061	CcSEcCtD
Amiodarone—Pruritus—Methotrexate—bone cancer	0.000169	0.000609	CcSEcCtD
Amiodarone—CYP2A6—Biological oxidations—GSTP1—bone cancer	0.000168	0.0012	CbGpPWpGaD
Amiodarone—CYP1A1—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	0.000168	0.0012	CbGpPWpGaD
Amiodarone—Hypersensitivity—Epirubicin—bone cancer	0.000165	0.000594	CcSEcCtD
Amiodarone—Urticaria—Doxorubicin—bone cancer	0.000164	0.000592	CcSEcCtD
Amiodarone—Body temperature increased—Doxorubicin—bone cancer	0.000164	0.00059	CcSEcCtD
Amiodarone—Abdominal pain—Doxorubicin—bone cancer	0.000164	0.00059	CcSEcCtD
Amiodarone—Diarrhoea—Methotrexate—bone cancer	0.000163	0.000589	CcSEcCtD
Amiodarone—EBP—Metabolism—GNA11—bone cancer	0.000163	0.00116	CbGpPWpGaD
Amiodarone—Asthenia—Epirubicin—bone cancer	0.00016	0.000578	CcSEcCtD
Amiodarone—CYP2C8—Arachidonic acid metabolism—PTGS2—bone cancer	0.00016	0.00114	CbGpPWpGaD
Amiodarone—Pruritus—Epirubicin—bone cancer	0.000158	0.00057	CcSEcCtD
Amiodarone—Dizziness—Methotrexate—bone cancer	0.000158	0.00057	CcSEcCtD
Amiodarone—CYP3A5—Biological oxidations—CYP3A4—bone cancer	0.000155	0.0011	CbGpPWpGaD
Amiodarone—CACNA1H—Developmental Biology—MET—bone cancer	0.000154	0.0011	CbGpPWpGaD
Amiodarone—CACNA1H—Developmental Biology—CDK4—bone cancer	0.000154	0.0011	CbGpPWpGaD
Amiodarone—Diarrhoea—Epirubicin—bone cancer	0.000153	0.000551	CcSEcCtD
Amiodarone—CYP3A5—Metapathway biotransformation—CYP3A4—bone cancer	0.000153	0.00109	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	0.000153	0.00109	CbGpPWpGaD
Amiodarone—Hypersensitivity—Doxorubicin—bone cancer	0.000152	0.000549	CcSEcCtD
Amiodarone—Vomiting—Methotrexate—bone cancer	0.000152	0.000548	CcSEcCtD
Amiodarone—Rash—Methotrexate—bone cancer	0.000151	0.000543	CcSEcCtD
Amiodarone—Dermatitis—Methotrexate—bone cancer	0.00015	0.000543	CcSEcCtD
Amiodarone—Headache—Methotrexate—bone cancer	0.00015	0.00054	CcSEcCtD
Amiodarone—Asthenia—Doxorubicin—bone cancer	0.000148	0.000535	CcSEcCtD
Amiodarone—KCNH2—SIDS Susceptibility Pathways—JUN—bone cancer	0.000148	0.00106	CbGpPWpGaD
Amiodarone—Dizziness—Epirubicin—bone cancer	0.000148	0.000533	CcSEcCtD
Amiodarone—EBP—Metabolism—CYP3A4—bone cancer	0.000147	0.00105	CbGpPWpGaD
Amiodarone—EBP—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	0.000147	0.00104	CbGpPWpGaD
Amiodarone—CYP1A1—Biological oxidations—CYP3A4—bone cancer	0.000146	0.00104	CbGpPWpGaD
Amiodarone—Pruritus—Doxorubicin—bone cancer	0.000146	0.000528	CcSEcCtD
Amiodarone—CYP1A2—Aryl Hydrocarbon Receptor—RB1—bone cancer	0.000145	0.00103	CbGpPWpGaD
Amiodarone—CYP1A1—Metapathway biotransformation—CYP3A4—bone cancer	0.000144	0.00103	CbGpPWpGaD
Amiodarone—CYP2C19—Arachidonic acid metabolism—PTGS2—bone cancer	0.000143	0.00102	CbGpPWpGaD
Amiodarone—Vomiting—Epirubicin—bone cancer	0.000142	0.000512	CcSEcCtD
Amiodarone—Nausea—Methotrexate—bone cancer	0.000142	0.000512	CcSEcCtD
Amiodarone—Diarrhoea—Doxorubicin—bone cancer	0.000142	0.00051	CcSEcCtD
Amiodarone—Rash—Epirubicin—bone cancer	0.000141	0.000508	CcSEcCtD
Amiodarone—Dermatitis—Epirubicin—bone cancer	0.000141	0.000508	CcSEcCtD
Amiodarone—Headache—Epirubicin—bone cancer	0.00014	0.000505	CcSEcCtD
Amiodarone—Dizziness—Doxorubicin—bone cancer	0.000137	0.000493	CcSEcCtD
Amiodarone—CYP1A2—Phase II conjugation—GSTP1—bone cancer	0.000137	0.000972	CbGpPWpGaD
Amiodarone—CACNA1H—Axon guidance—MMP9—bone cancer	0.000135	0.000965	CbGpPWpGaD
Amiodarone—CYP2C8—Biological oxidations—CYP3A4—bone cancer	0.000134	0.000956	CbGpPWpGaD
Amiodarone—CACNA2D2—Metabolism—ENO2—bone cancer	0.000134	0.000951	CbGpPWpGaD
Amiodarone—Nausea—Epirubicin—bone cancer	0.000133	0.000479	CcSEcCtD
Amiodarone—CYP3A5—Biological oxidations—GSTP1—bone cancer	0.000133	0.000944	CbGpPWpGaD
Amiodarone—CYP2C8—Metapathway biotransformation—CYP3A4—bone cancer	0.000132	0.000943	CbGpPWpGaD
Amiodarone—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	0.000132	0.000941	CbGpPWpGaD
Amiodarone—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—bone cancer	0.000132	0.000941	CbGpPWpGaD
Amiodarone—Vomiting—Doxorubicin—bone cancer	0.000132	0.000474	CcSEcCtD
Amiodarone—CYP3A5—Metapathway biotransformation—GSTP1—bone cancer	0.000131	0.000931	CbGpPWpGaD
Amiodarone—Rash—Doxorubicin—bone cancer	0.00013	0.00047	CcSEcCtD
Amiodarone—Dermatitis—Doxorubicin—bone cancer	0.00013	0.00047	CcSEcCtD
Amiodarone—CYP2C9—Arachidonic acid metabolism—PTGS2—bone cancer	0.00013	0.000926	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	0.00013	0.000924	CbGpPWpGaD
Amiodarone—Headache—Doxorubicin—bone cancer	0.00013	0.000467	CcSEcCtD
Amiodarone—CACNA1H—Developmental Biology—MMP2—bone cancer	0.000129	0.000916	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—NDUFA12—bone cancer	0.000129	0.000915	CbGpPWpGaD
Amiodarone—ADRB1—GPCR ligand binding—SMO—bone cancer	0.000128	0.000911	CbGpPWpGaD
Amiodarone—KCNH2—Neuronal System—BRAF—bone cancer	0.000128	0.00091	CbGpPWpGaD
Amiodarone—EBP—Metabolism—GSTP1—bone cancer	0.000126	0.000898	CbGpPWpGaD
Amiodarone—CYP1A1—Biological oxidations—GSTP1—bone cancer	0.000125	0.000892	CbGpPWpGaD
Amiodarone—CACNA2D2—Metabolism—DHFR—bone cancer	0.000124	0.000883	CbGpPWpGaD
Amiodarone—CYP1A1—Metapathway biotransformation—GSTP1—bone cancer	0.000124	0.00088	CbGpPWpGaD
Amiodarone—CYP1A2—Tryptophan metabolism—MDM2—bone cancer	0.000123	0.000878	CbGpPWpGaD
Amiodarone—Nausea—Doxorubicin—bone cancer	0.000123	0.000443	CcSEcCtD
Amiodarone—CYP2C19—Biological oxidations—CYP3A4—bone cancer	0.00012	0.000853	CbGpPWpGaD
Amiodarone—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—bone cancer	0.000119	0.000846	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—GRM4—bone cancer	0.000118	0.000843	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—RGS1—bone cancer	0.000118	0.000843	CbGpPWpGaD
Amiodarone—CYP2C19—Metapathway biotransformation—CYP3A4—bone cancer	0.000118	0.000842	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	0.000118	0.000841	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—NDUFA12—bone cancer	0.000118	0.000839	CbGpPWpGaD
Amiodarone—CACNA2D2—Metabolism—GNA11—bone cancer	0.000116	0.000825	CbGpPWpGaD
Amiodarone—CYP2C8—Biological oxidations—GSTP1—bone cancer	0.000115	0.000818	CbGpPWpGaD
Amiodarone—CYP2C8—Metapathway biotransformation—GSTP1—bone cancer	0.000113	0.000806	CbGpPWpGaD
Amiodarone—CYP1A2—Arachidonic acid metabolism—PTGS2—bone cancer	0.000111	0.000792	CbGpPWpGaD
Amiodarone—CYP2D6—Biological oxidations—CYP3A4—bone cancer	0.00011	0.000785	CbGpPWpGaD
Amiodarone—CACNA1H—Axon guidance—EGFR—bone cancer	0.000109	0.00078	CbGpPWpGaD
Amiodarone—CYP2C9—Biological oxidations—CYP3A4—bone cancer	0.000109	0.000778	CbGpPWpGaD
Amiodarone—CYP2D6—Metapathway biotransformation—CYP3A4—bone cancer	0.000109	0.000774	CbGpPWpGaD
Amiodarone—CYP2C9—Metapathway biotransformation—CYP3A4—bone cancer	0.000108	0.000767	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	0.000108	0.000766	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—GRM4—bone cancer	0.000108	0.000766	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—RGS1—bone cancer	0.000108	0.000766	CbGpPWpGaD
Amiodarone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	0.000107	0.000763	CbGpPWpGaD
Amiodarone—KCNH2—Neuronal System—MDM2—bone cancer	0.000107	0.000763	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—NT5C3A—bone cancer	0.000107	0.000758	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	0.000106	0.000756	CbGpPWpGaD
Amiodarone—CACNA2D2—Metabolism—CYP3A4—bone cancer	0.000105	0.000748	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—GRM1—bone cancer	0.000103	0.000731	CbGpPWpGaD
Amiodarone—CYP2C19—Biological oxidations—GSTP1—bone cancer	0.000102	0.00073	CbGpPWpGaD
Amiodarone—CYP2C19—Metapathway biotransformation—GSTP1—bone cancer	0.000101	0.00072	CbGpPWpGaD
Amiodarone—ABCB1—HIF-1-alpha transcription factor network—JUN—bone cancer	0.000101	0.000716	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—NT5C3A—bone cancer	9.76e-05	0.000695	CbGpPWpGaD
Amiodarone—CACNA1H—Developmental Biology—MMP9—bone cancer	9.67e-05	0.000688	CbGpPWpGaD
Amiodarone—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	9.51e-05	0.000677	CbGpPWpGaD
Amiodarone—CYP2D6—Biological oxidations—GSTP1—bone cancer	9.43e-05	0.000671	CbGpPWpGaD
Amiodarone—CYP2C9—Biological oxidations—GSTP1—bone cancer	9.35e-05	0.000666	CbGpPWpGaD
Amiodarone—CYP1A2—Biological oxidations—CYP3A4—bone cancer	9.34e-05	0.000665	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—GRM1—bone cancer	9.32e-05	0.000664	CbGpPWpGaD
Amiodarone—CYP2D6—Metapathway biotransformation—GSTP1—bone cancer	9.3e-05	0.000662	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—NDUFA12—bone cancer	9.29e-05	0.000662	CbGpPWpGaD
Amiodarone—CYP2C9—Metapathway biotransformation—GSTP1—bone cancer	9.22e-05	0.000656	CbGpPWpGaD
Amiodarone—CYP1A2—Metapathway biotransformation—CYP3A4—bone cancer	9.21e-05	0.000656	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	8.99e-05	0.00064	CbGpPWpGaD
Amiodarone—CACNA2D2—Metabolism—GSTP1—bone cancer	8.98e-05	0.00064	CbGpPWpGaD
Amiodarone—ABCB1—Transmembrane transport of small molecules—TUBB4B—bone cancer	8.97e-05	0.000639	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—NDUFA12—bone cancer	8.78e-05	0.000625	CbGpPWpGaD
Amiodarone—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—bone cancer	8.42e-05	0.0006	CbGpPWpGaD
Amiodarone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	8.42e-05	0.0006	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—NDUFA12—bone cancer	8.05e-05	0.000573	CbGpPWpGaD
Amiodarone—CYP1A2—Biological oxidations—GSTP1—bone cancer	7.99e-05	0.000569	CbGpPWpGaD
Amiodarone—CYP1A2—Metapathway biotransformation—GSTP1—bone cancer	7.88e-05	0.000561	CbGpPWpGaD
Amiodarone—CACNA1H—Developmental Biology—EGFR—bone cancer	7.81e-05	0.000556	CbGpPWpGaD
Amiodarone—ABCB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	7.74e-05	0.000551	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—NT5C3A—bone cancer	7.7e-05	0.000548	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—NT5C3A—bone cancer	7.27e-05	0.000518	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—NDUFA12—bone cancer	7.18e-05	0.000512	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—NDUFA12—bone cancer	7.01e-05	0.000499	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	6.67e-05	0.000475	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—NT5C3A—bone cancer	6.67e-05	0.000475	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—GNA11—bone cancer	6.62e-05	0.000471	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—NDUFA12—bone cancer	6.61e-05	0.00047	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—SMO—bone cancer	6.57e-05	0.000468	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—NDUFA12—bone cancer	6.55e-05	0.000466	CbGpPWpGaD
Amiodarone—EBP—Metabolism—PTGS2—bone cancer	6.53e-05	0.000465	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—GRM4—bone cancer	6.35e-05	0.000452	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—RGS1—bone cancer	6.35e-05	0.000452	CbGpPWpGaD
Amiodarone—CYP3A4—Biological oxidations—GSTP1—bone cancer	6.16e-05	0.000439	CbGpPWpGaD
Amiodarone—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	6.08e-05	0.000433	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—GNA11—bone cancer	6.01e-05	0.000428	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—IL3—bone cancer	6e-05	0.000427	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—NT5C3A—bone cancer	5.95e-05	0.000424	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—NT5C3A—bone cancer	5.81e-05	0.000414	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—NDUFA12—bone cancer	5.6e-05	0.000399	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—GRM1—bone cancer	5.51e-05	0.000392	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—NT5C3A—bone cancer	5.47e-05	0.00039	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—IL3—bone cancer	5.45e-05	0.000388	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—NT5C3A—bone cancer	5.43e-05	0.000386	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	4.94e-05	0.000352	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	4.77e-05	0.000339	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—ENO2—bone cancer	4.67e-05	0.000332	CbGpPWpGaD
Amiodarone—CACNA2D2—Metabolism—PTGS2—bone cancer	4.65e-05	0.000331	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—NT5C3A—bone cancer	4.64e-05	0.00033	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—DHFR—bone cancer	4.33e-05	0.000308	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—NDUFA12—bone cancer	4.32e-05	0.000308	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	4.3e-05	0.000306	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—ENO2—bone cancer	4.28e-05	0.000305	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—GNA11—bone cancer	4.05e-05	0.000288	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—DHFR—bone cancer	3.97e-05	0.000283	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—SMO—bone cancer	3.88e-05	0.000276	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—GNA11—bone cancer	3.71e-05	0.000264	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—CYP3A4—bone cancer	3.67e-05	0.000261	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—NT5C3A—bone cancer	3.58e-05	0.000255	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—GNA11—bone cancer	3.55e-05	0.000253	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	3.38e-05	0.000241	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—ENO2—bone cancer	3.37e-05	0.00024	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—CYP3A4—bone cancer	3.36e-05	0.000239	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—ATF1—bone cancer	3.3e-05	0.000235	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—IL3—bone cancer	3.22e-05	0.000229	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—ENO2—bone cancer	3.19e-05	0.000227	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—GSTP1—bone cancer	3.14e-05	0.000223	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—DHFR—bone cancer	3.13e-05	0.000223	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—DHFR—bone cancer	2.96e-05	0.00021	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—GNA11—bone cancer	2.92e-05	0.000208	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—ENO2—bone cancer	2.92e-05	0.000208	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—GSTP1—bone cancer	2.87e-05	0.000205	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	2.84e-05	0.000202	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—GNA11—bone cancer	2.76e-05	0.000197	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—TGFBR2—bone cancer	2.75e-05	0.000196	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—DHFR—bone cancer	2.71e-05	0.000193	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—CYP3A4—bone cancer	2.65e-05	0.000189	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—ENO2—bone cancer	2.61e-05	0.000186	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—IGF1R—bone cancer	2.59e-05	0.000184	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—ENO2—bone cancer	2.54e-05	0.000181	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—GNA11—bone cancer	2.53e-05	0.00018	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—CYP3A4—bone cancer	2.5e-05	0.000178	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.49e-05	0.000177	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—DHFR—bone cancer	2.42e-05	0.000172	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—ENO2—bone cancer	2.4e-05	0.000171	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—ENO2—bone cancer	2.38e-05	0.000169	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—DHFR—bone cancer	2.36e-05	0.000168	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—CYP3A4—bone cancer	2.3e-05	0.000164	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.28e-05	0.000163	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—GSTP1—bone cancer	2.27e-05	0.000161	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—GNA11—bone cancer	2.26e-05	0.000161	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—DHFR—bone cancer	2.22e-05	0.000158	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—GNA11—bone cancer	2.21e-05	0.000157	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—DHFR—bone cancer	2.21e-05	0.000157	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—GSTP1—bone cancer	2.14e-05	0.000153	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—GNA11—bone cancer	2.08e-05	0.000148	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—GNA11—bone cancer	2.06e-05	0.000147	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—CYP3A4—bone cancer	2.05e-05	0.000146	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.04e-05	0.000145	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—ENO2—bone cancer	2.03e-05	0.000145	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—CYP3A4—bone cancer	2e-05	0.000142	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—GSTP1—bone cancer	1.96e-05	0.00014	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—CYP3A4—bone cancer	1.89e-05	0.000134	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—DHFR—bone cancer	1.88e-05	0.000134	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—KIT—bone cancer	1.88e-05	0.000134	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—CYP3A4—bone cancer	1.87e-05	0.000133	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.86e-05	0.000132	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—BRAF—bone cancer	1.77e-05	0.000126	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—GNA11—bone cancer	1.76e-05	0.000125	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—GSTP1—bone cancer	1.75e-05	0.000125	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—GSTP1—bone cancer	1.71e-05	0.000122	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—EGFR—bone cancer	1.71e-05	0.000122	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—PTGS2—bone cancer	1.62e-05	0.000116	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—GSTP1—bone cancer	1.61e-05	0.000115	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—GSTP1—bone cancer	1.6e-05	0.000114	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—CYP3A4—bone cancer	1.6e-05	0.000114	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.59e-05	0.000113	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—ENO2—bone cancer	1.57e-05	0.000112	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—PTGS2—bone cancer	1.49e-05	0.000106	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—MDM2—bone cancer	1.48e-05	0.000105	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—DHFR—bone cancer	1.45e-05	0.000104	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—GSTP1—bone cancer	1.37e-05	9.73e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—GNA11—bone cancer	1.36e-05	9.68e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—JUN—bone cancer	1.29e-05	9.15e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—MMP9—bone cancer	1.25e-05	8.91e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—PTGS2—bone cancer	1.17e-05	8.36e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PTGS2—bone cancer	1.11e-05	7.9e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—GSTP1—bone cancer	1.05e-05	7.51e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PTGS2—bone cancer	1.02e-05	7.24e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—EGFR—bone cancer	1.01e-05	7.2e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PTGS2—bone cancer	9.08e-06	6.47e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PTGS2—bone cancer	8.86e-06	6.31e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—TP53—bone cancer	8.49e-06	6.04e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PTGS2—bone cancer	8.35e-06	5.95e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PTGS2—bone cancer	8.28e-06	5.9e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PTGS2—bone cancer	7.08e-06	5.04e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PTGS2—bone cancer	5.46e-06	3.89e-05	CbGpPWpGaD
